Is liver biopsy a useful predictor of response to interferon therapy in chronic hepatitis C?
Liver biopsy provides useful information for selection of patients with hepatitis C for IFN therapy.
The association of genes from the RANK/RANKL/OPG pathway and BMDC provides new insight into how this system might affect the skeleton, confirming it to be associated with volumetric cortical bone density but observing no relationship with bone size.